Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...
Morgan Stanley has recently reduced ING Groep NV (ING) stock rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 22, 2024, Barclays had reduced the stock from a ...
On Friday, DexCom Inc (DXCM) stock saw a decline, ending the day at $80.24 which represents a decrease of $-0.33 or -0.41% from the prior close of $80.57. The stock opened at $80.03 and touched a low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback